OptimizeRx Corporation (OPRX)
USD 8.33
(2.46%)
USD 8.33
(2.46%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 71.52 Million USD | 14.53% |
| 2022 | 62.45 Million USD | 1.89% |
| 2021 | 61.29 Million USD | 41.51% |
| 2020 | 43.31 Million USD | 76.08% |
| 2019 | 24.59 Million USD | 15.99% |
| 2018 | 21.2 Million USD | 74.86% |
| 2017 | 12.12 Million USD | 56.45% |
| 2016 | 7.75 Million USD | 7.35% |
| 2015 | 7.22 Million USD | 11.04% |
| 2014 | 6.5 Million USD | 31.19% |
| 2013 | 4.95 Million USD | 141.96% |
| 2012 | 2.04 Million USD | 84.32% |
| 2011 | 1.11 Million USD | 1464.09% |
| 2010 | 71.06 Thousand USD | 165.93% |
| 2009 | 26.72 Thousand USD | -68.07% |
| 2008 | 83.68 Thousand USD | -16.58% |
| 2007 | 100.31 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 19.69 Million USD | -30.59% |
| 2024 Q2 | 18.81 Million USD | -4.46% |
| 2023 FY | 71.52 Million USD | 14.53% |
| 2023 Q3 | 16.33 Million USD | 18.19% |
| 2023 Q4 | 28.36 Million USD | 73.71% |
| 2023 Q1 | 13 Million USD | -33.84% |
| 2023 Q2 | 13.81 Million USD | 6.27% |
| 2022 Q1 | 13.73 Million USD | -32.4% |
| 2022 Q4 | 19.65 Million USD | 30.29% |
| 2022 FY | 62.45 Million USD | 1.89% |
| 2022 Q2 | 13.97 Million USD | 1.8% |
| 2022 Q3 | 15.08 Million USD | 7.92% |
| 2021 Q1 | 11.22 Million USD | -31.64% |
| 2021 FY | 61.29 Million USD | 41.51% |
| 2021 Q2 | 13.62 Million USD | 21.34% |
| 2021 Q3 | 16.12 Million USD | 18.34% |
| 2021 Q4 | 20.31 Million USD | 25.97% |
| 2020 Q1 | 7.58 Million USD | 2.78% |
| 2020 FY | 43.31 Million USD | 76.08% |
| 2020 Q3 | 10.51 Million USD | 19.76% |
| 2020 Q2 | 8.78 Million USD | 15.8% |
| 2020 Q4 | 16.42 Million USD | 56.16% |
| 2019 Q3 | 5 Million USD | -28.6% |
| 2019 FY | 24.59 Million USD | 15.99% |
| 2019 Q1 | 5.2 Million USD | -20.82% |
| 2019 Q4 | 7.37 Million USD | 47.51% |
| 2019 Q2 | 7 Million USD | 34.49% |
| 2018 Q4 | 6.57 Million USD | 21.49% |
| 2018 FY | 21.2 Million USD | 74.86% |
| 2018 Q3 | 5.41 Million USD | 6.19% |
| 2018 Q2 | 5.09 Million USD | 24.01% |
| 2018 Q1 | 4.11 Million USD | 2.63% |
| 2017 Q3 | 3.1 Million USD | 8.26% |
| 2017 Q4 | 4 Million USD | 29.15% |
| 2017 Q1 | 2.15 Million USD | -6.13% |
| 2017 Q2 | 2.86 Million USD | 33.17% |
| 2017 FY | 12.12 Million USD | 56.45% |
| 2016 Q1 | 1.75 Million USD | -12.91% |
| 2016 Q3 | 1.78 Million USD | -6.65% |
| 2016 Q2 | 1.91 Million USD | 8.74% |
| 2016 Q4 | 2.29 Million USD | 28.35% |
| 2016 FY | 7.75 Million USD | 7.35% |
| 2015 Q2 | 1.7 Million USD | 14.65% |
| 2015 Q4 | 2.02 Million USD | 0.64% |
| 2015 Q3 | 2 Million USD | 17.71% |
| 2015 FY | 7.22 Million USD | 11.04% |
| 2015 Q1 | 1.48 Million USD | -29.54% |
| 2014 Q3 | 1.62 Million USD | 11.42% |
| 2014 Q4 | 2.11 Million USD | 30.3% |
| 2014 FY | 6.5 Million USD | 31.19% |
| 2014 Q1 | 1.31 Million USD | -27.24% |
| 2014 Q2 | 1.45 Million USD | 10.39% |
| 2013 FY | 4.95 Million USD | 141.96% |
| 2013 Q1 | 669.29 Thousand USD | -10.85% |
| 2013 Q4 | 1.81 Million USD | 31.87% |
| 2013 Q2 | 1.1 Million USD | 64.96% |
| 2013 Q3 | 1.37 Million USD | 24.36% |
| 2012 Q2 | 515.42 Thousand USD | 56.47% |
| 2012 Q1 | 329.4 Thousand USD | 1.07% |
| 2012 FY | 2.04 Million USD | 84.32% |
| 2012 Q4 | 750.71 Thousand USD | 65.67% |
| 2012 Q3 | 453.15 Thousand USD | -12.08% |
| 2011 Q3 | 191.59 Thousand USD | -4.29% |
| 2011 Q1 | 393.84 Thousand USD | 3079.74% |
| 2011 Q2 | 200.17 Thousand USD | -49.17% |
| 2011 Q4 | 325.91 Thousand USD | 70.11% |
| 2011 FY | 1.11 Million USD | 1464.09% |
| 2010 Q1 | 1283.00 USD | -91.5% |
| 2010 Q3 | 40.67 Thousand USD | 143.28% |
| 2010 FY | 71.06 Thousand USD | 165.93% |
| 2010 Q2 | 16.72 Thousand USD | 1203.2% |
| 2010 Q4 | 12.38 Thousand USD | -69.55% |
| 2009 Q4 | 15.09 Thousand USD | 118.51% |
| 2009 FY | 26.72 Thousand USD | -68.07% |
| 2009 Q3 | 6908.00 USD | 100.29% |
| 2009 Q2 | 3449.00 USD | 171.36% |
| 2009 Q1 | 1271.00 USD | -91.73% |
| 2008 Q1 | 50.52 Thousand USD | 0.0% |
| 2008 Q3 | 1111.00 USD | -93.34% |
| 2008 Q2 | 16.67 Thousand USD | -66.99% |
| 2008 FY | 83.68 Thousand USD | -16.58% |
| 2008 Q4 | 15.36 Thousand USD | 1283.35% |
| 2007 FY | 100.31 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Augmedix, Inc. | 44.85 Million USD | -59.45% |
| OneMedNet Corporation | 1.02 Million USD | -6900.581% |
| Minerva Surgical, Inc. | 50.29 Million USD | -42.207% |
| CareCloud, Inc. | 117.05 Million USD | 38.901% |
| CareCloud, Inc. | 117.05 Million USD | 38.901% |
| HealthEquity, Inc. | 999.58 Million USD | 92.845% |
| iCoreConnect Inc. | 8.15 Million USD | -777.394% |
| Progyny, Inc. | 1.08 Billion USD | 93.43% |
| Renalytix Plc | 2.28 Million USD | -3024.574% |
| Schrödinger, Inc. | 216.66 Million USD | 66.99% |
| Simulations Plus, Inc. | 70.01 Million USD | -2.155% |
| SOPHiA GENETICS SA | 62.37 Million USD | -14.671% |
| Omnicell, Inc. | 1.14 Billion USD | 93.765% |
| BrightSpring Health Services, Inc. Common Stock | 8.82 Billion USD | 99.19% |
| Streamline Health Solutions, Inc. | 22.59 Million USD | -216.523% |
| Inovalon Holdings, Inc. | 667.52 Million USD | 89.286% |
| Ontrak, Inc. | 12.74 Million USD | -461.261% |
| Nutex Health, Inc. | 247.64 Million USD | 71.119% |
| GE HealthCare Technologies Inc. | 19.55 Billion USD | 99.634% |
| Sharecare, Inc. | 445.25 Million USD | 83.937% |
| Aclarion, Inc. | 75.4 Thousand USD | -94751.077% |
| CareMax, Inc. | 751.1 Million USD | 90.478% |
| Bullfrog AI Holdings, Inc. Common Stock | 65 Thousand USD | -109933.086% |
| Forian Inc. | 20.48 Million USD | -249.203% |
| Bullfrog AI Holdings, Inc. Warrants | 65 Thousand USD | -109933.086% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 202.56 Million USD | 64.692% |
| SCWorx Corp. | 3.8 Million USD | -1779.7% |
| Definitive Healthcare Corp. | 251.41 Million USD | 71.552% |
| 10x Genomics, Inc. | 618.72 Million USD | 88.441% |
| Zhongchao Inc. | 19.43 Million USD | -268.024% |
| Accolade, Inc. | 414.29 Million USD | 82.736% |
| MSP Recovery, Inc. | 7.7 Million USD | -828.248% |
| R1 RCM Inc. | 2.25 Billion USD | 96.827% |
| Spok Holdings, Inc. | 139.02 Million USD | 48.555% |
| Privia Health Group, Inc. | 1.65 Billion USD | 95.686% |
| EUDA Health Holdings Limited | 3.7 Million USD | -1829.646% |
| TruBridge, Inc. | 339.43 Million USD | 78.929% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 8.82 Billion USD | 99.19% |
| Sharecare, Inc. | 445.25 Million USD | 83.937% |
| Health Catalyst, Inc. | 295.93 Million USD | 75.832% |
| GoodRx Holdings, Inc. | 750.26 Million USD | 90.467% |
| Premier, Inc. | 1.34 Billion USD | 94.688% |
| HealthStream, Inc. | 279.06 Million USD | 74.371% |
| Certara, Inc. | 354.33 Million USD | 79.815% |
| GeneDx Holdings Corp. | 202.56 Million USD | 64.692% |
| Ontrak, Inc. | 12.74 Million USD | -461.261% |
| SHL Telemedicine Ltd. | 57.07 Million USD | -25.311% |
| CareCloud, Inc. | 117.05 Million USD | 38.901% |
| EUDA Health Holdings Limited | 3.7 Million USD | -1829.646% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 731.49 Thousand USD | -9677.47% |
| CareMax, Inc. | 751.1 Million USD | 90.478% |
| Healthcare Triangle, Inc. | 33.2 Million USD | -115.407% |
| National Research Corporation | 148.58 Million USD | 51.863% |
| Aclarion, Inc. | 75.4 Thousand USD | -94751.077% |